BiomX Inc. — Investor Relations & Filings
Filings indexed
513
across all filing types
Latest filing
2022-08-24
Director's Dealing
Country
US
United States of America
Listing
US
PHGE
BiomX Inc. is a clinical-stage company developing phage therapies to target and destroy harmful bacteria. The company creates both natural and engineered phage cocktails and personalized treatments for chronic diseases. Its therapeutic pipeline focuses on conditions such as cystic fibrosis and diabetic foot osteomyelitis. BiomX's platform discovers and validates proprietary bacterial targets, allowing for the customization of phage compositions against these specific pathogens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2022 | 2022-08-24 | English | |
| QUARTERLY REPORT | 2022-08-10 | English | |
| CURRENT REPORT | 2022-08-10 | English | |
| SC 13G/A | 2022-08-05 | English | |
| DEFINITIVE ADDITIONAL MATERIALS | 2022-07-07 | English | |
| DEFINITIVE PROXY STATEMENT | 2022-07-07 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 13110219 | Director's Dealing 2022 | 2022-08-24 | English | ||
| 13110220 | QUARTERLY REPORT | 2022-08-10 | English | ||
| 13110221 | CURRENT REPORT | 2022-08-10 | English | ||
| 13110222 | SC 13G/A | 2022-08-05 | English | ||
| 13110223 | DEFINITIVE ADDITIONAL MATERIALS | 2022-07-07 | English | ||
| 13110224 | DEFINITIVE PROXY STATEMENT | 2022-07-07 | English | ||
| 13110226 | CURRENT REPORT | 2022-07-06 | English | ||
| 13110225 | CURRENT REPORT | 2022-06-27 | English | ||
| 13110227 | PRELIMINARY PROXY STATEMENT | 2022-06-21 | English | ||
| 13110228 | CURRENT REPORT | 2022-06-14 | English | ||
| 13110229 | CURRENT REPORT | 2022-05-24 | English | ||
| 13110230 | QUARTERLY REPORT | 2022-05-11 | English | ||
| 13110231 | CURRENT REPORT | 2022-05-11 | English | ||
| 13110232 | AMENDMENT NO. 1 TO FORM 10-K | 2022-05-02 | English | ||
| 13110233 | PROSPECTUS SUPPLEMENT | 2022-04-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BiomX Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35099/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35099 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35099 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35099 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35099}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BiomX Inc. (id: 35099)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.